Sanofi India Limited Overview
Pro stress-test →Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
Strategic Profile
Pro stress-test →The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health. It also exports its products to approximately 24 countries.
Competitive Landscape
Pro stress-test →Sanofi India competes in India's highly fragmented pharmaceutical market against major generic manufacturers and multinational peers. Its competitive advantage lies in the branded insulin franchise (31% market share), diverse therapeutic portfolio, and export capabilities across 24 countries. However, it faces pricing pressure and generic competition typical of the Indian market.
Industry Context
Sanofi India Limited operates in Pharmaceuticals & Biotechnology.
Key facts
Founded: 1956 · Headquarters: Mumbai, Maharashtra, India · Employees: 1,225 · Revenue: ₹20.13B (FY2024) · Market cap: ₹9,237 Cr (~$1.1B USD)